Pure Global

Access HIV combo - Taiwan Registration b213e5fec233bb7cab40b56e74e281d4

Access comprehensive regulatory information for Access HIV combo in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number b213e5fec233bb7cab40b56e74e281d4 and manufactured by BIO-RAD. The authorized representative in Taiwan is Bio-Rad Laboratories Inc., Taiwan Branch (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
b213e5fec233bb7cab40b56e74e281d4
Registration Details
Taiwan FDA Registration: b213e5fec233bb7cab40b56e74e281d4
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Access HIV combo
TW: ไบž็‘Ÿๆ–ฏๆ„›ๆป‹็—…ๆฏ’็ถœๅˆๆชข้ฉ—่ฉฆๅŠ‘็ต„
Risk Class 3
MD

Registration Details

b213e5fec233bb7cab40b56e74e281d4

Ministry of Health Medical Device Import No. 030090

DHA05603009001

Company Information

France

Product Details

This product uses the Access immunoassay system to qualitatively detect HIV-1 p24 antigen and HIV-1 (M and O) and HIV-2 antibodies in human serum and plasma (Li-heparin, K2-EDTA, K3-EDTA and CPDA-1) using paramagnetic particle chemical cold light immunoassay. This product can be used as a diagnostic aid for HIV-1 and HIV-2 infection and a screening test for blood and plasma donors. This product cannot be used for mixed specimen testing or screening. The test results of this product cannot distinguish between HIV-1 p24 antigen, HIV-1 or HIV-1-O or HIV-2 antibodies.

B Hematology and pathology devices

B4020 Analyze specific reagents

Imported from abroad

Dates and Status

Nov 01, 2017

Nov 01, 2027